Estella

Researchers are evaluating whether taking the Ovosicare4 Fertility food supplement can increase the chance of becoming pregnant in women aged 32 to 38 years who have been trying to conceive for at least six months. This observational study focuses on fertility and aims to understand the supplement's impact on spontaneous pregnancy rates within this age group. Participants will take the Ovosicare4 Fertility supplement, which contains a combination of MYO/DCI in a 3.6:1 ratio, antioxidants, vitamins, and minerals. The study does not involve extra tests or visits beyond routine clinical care. Each participant will be followed for up to 18 months, or until pregnancy occurs, whichever happens first. During the study, participants will attend a total of three visits. The researchers will monitor pregnancy occurrence over a maximum of nine months after starting supplementation to assess the rate of spontaneous pregnancy. No additional procedures are required beyond usual clinical practice, making participation convenient and integrated into regular healthcare visits.